Literature DB >> 4645609

Pseudomyxoma peritonei.

B C Ghosh, A G Huvos, H W Whiteley.   

Abstract

Entities:  

Mesh：

Year:  1972        PMID： 4645609     DOI： 10.1007/bf02642643

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN： 0012-3706            Impact factor:   4.585


× No keyword cloud information.
  6 in total

1.  Primary adenocarcinoma of appendix, colonic type associated with perforating peritonitis in an elderly patient.

Authors:  T Yamada; Y Murao; T Nakamura; H Tabuse; S Miyamoto; S Imai; H Nakano
Journal:  J Gastroenterol       Date:  1997-10       Impact factor: 7.527

2.  Calcified rims: characteristics but uncommon radiologic finding in pseudomyxoma peritonei.

Authors:  H N Douds; M J Pitt
Journal:  Gastrointest Radiol       Date:  1980-08-15

Review 3.  Intraperitoneal immunotherapy: historical perspectives and modern therapy.

Authors:  W F Morano; A Aggarwal; P Love; S D Richard; J Esquivel; W B Bowne
Journal:  Cancer Gene Ther       Date:  2016-11-11       Impact factor: 5.987

Review 4.  Then and now: cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC), a historical perspective.

Authors:  Madalyn G Neuwirth; H Richard Alexander; Giorgos C Karakousis
Journal:  J Gastrointest Oncol       Date:  2016-02

Review 5.  Status of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer.

Authors:  Seung Yoon Yang; Jae Hyun Kang; Ho Seung Kim; Yoon Dae Han; Byung Soh Min; Kang Young Lee
Journal:  J Gastrointest Oncol       Date:  2019-12

6.  PIPAC for the Treatment of Gynecologic and Gastrointestinal Peritoneal Metastases: Technical and Logistic Considerations of a Phase 1 Trial.

Authors:  Mustafa Raoof; Gautam Malhotra; Adrian Kohut; Michael O'Leary; Paul Frankel; Thuy Tran; Marwan Fakih; Joseph Chao; Dean Lim; Yanghee Woo; Isaac B Paz; Michael Lew; Mihaela C Cristea; Lorna Rodriguez-Rodriguez; Yuman Fong; Andrew Blakely; Richard Whelan; Marc A Reymond; Amit Merchea; Thanh H Dellinger
Journal:  Ann Surg Oncol       Date:  2021-08-13       Impact factor: 5.344
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.